How many insider trades does FilingIQ track for NVAX?

FilingIQ tracks 1,334 Form 4 insider transactions for NVAX (NOVAVAX INC), covering filings from Feb 3, 2015 onwards. 0 of those are dated within the last 90 days.

Are NVAX insiders net buyers or net sellers?

Across the full Form 4 history for NVAX, 52 transactions (4%) were open-market purchases and 825 (62%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does NVAX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.

What sector is NVAX in?

NOVAVAX INC (NVAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.56B.

NVAX insider trading

NasdaqGS Healthcare

NOVAVAX INC: insider trade history from SEC Form 4 filings.

Total Form 4 trades

1,334

Last 90 days

Buys / sells

4% / 62%

Market cap

$1.56B

About NOVAVAX INC

Novavax, Inc., a biotechnology company, engages in the discovering, developing, and commercializing vaccines to protect against serious infectious diseases in the United States, Europe, and internationally. The company offers vaccine platform that combines a recombinant protein approach, nanoparticle technology, and its patented Matrix-M adjuvant to enhance the immune response. The company is commercializing a COVID-19 vaccine, NVX-CoV2373 under the brand names of Nuvaxovid, Covovax, and Novavax COVID-19 Vaccine, adjuvanted for adult and adolescent populations as a primary series and for both homologous and heterologous booster indications. It also developing R21/Matrix-M adjuvant malaria vaccine. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.

Company website: www.novavax.com

NVAX insider activity at a glance

FilingIQ tracks 1,334 insider transactions for NVAX in filings since Feb 3, 2015. The most recent transaction is dated Jun 20, 2026.

Across the full history, 52 open-market purchases and 825 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on NVAX insider trades is 60.8/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live NVAX trades on FilingIQ Raw filings on SEC EDGAR

Latest NVAX Form 4 filings

Walker Robert Edward EVP, R&D

A Apr 16, 2026

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 820

UNITED THERAPEUTICS Corp

THERMO FISHER SCIENTIFIC INC.

NTRA 129

Natera, Inc.

ATTO 123

Attovia Therapeutics, Inc.

CORT 110

CORCEPT THERAPEUTICS INC

TEM 104

Tempus AI, Inc.

Frequently asked

How many insider trades does FilingIQ track for NVAX?: FilingIQ tracks 1,334 Form 4 insider transactions for NVAX (NOVAVAX INC), covering filings from Feb 3, 2015 onwards. 0 of those are dated within the last 90 days.
Are NVAX insiders net buyers or net sellers?: Across the full Form 4 history for NVAX, 52 transactions (4%) were open-market purchases and 825 (62%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does NVAX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ normalises insider identity across reporting variations and scores discretionary open-market purchases and sales on its multi-factor composite model.
What sector is NVAX in?: NOVAVAX INC (NVAX) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $1.56B.

Methodology & sources

Every NVAX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.